Clinical trial
Neoadjuvant-Adjuvant Versus Adjuvant-Only Therapy Combined With Endoscopic Surgery in Advanced Recurrent Nasopharyngeal Carcinoma:A Multicenter Randomized Controlled Trial
NCT06235203 is registered in ClinicalTrials.gov with Eye & ENT Hospital of Fudan University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Neoadjuvant-Adjuvant Versus Adjuvant-Only Therapy Combined With Endoscopic Surgery in Advanced Recurrent Nasopharyngeal Carcinoma:A Multicenter Randomized Controlled Trial
- Lead sponsor
- Eye & ENT Hospital of Fudan University
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- July 9, 2024
- Completion date
- June 30, 2027
- Enrollment
- 154 (estimated)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
recurrent nasopharyngeal carcinoma